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Hedgehog (Hh) signaling in vertebrates depends on intraflagellar transport (IFT) within primary cilia. The
Hh receptor Patched is found in cilia in the absence of Hh and is replaced by the signal transducer Smoothened
within an hour of Hh stimulation. By generating antibodies capable of detecting endogenous pathway tran-
scription factors Gli2 and Gli3, we monitored their kinetics of accumulation in cilia upon Hh stimulation.
Localization occurs within minutes of Hh addition, making it the fastest reported readout of pathway activity,
which permits more precise temporal and spatial localization of Hh signaling events. We show that the species
of Gli3 that accumulates at cilium tips is full-length and likely not protein kinase A phosphorylated. We also
confirmed that phosphorylation and TrCP/Cul1 are required for endogenous Gli3 processing and that this is
inhibited by Hh. Surprisingly, however, Hh-dependent inhibition of processing does not lead to accumulation
of full-length Gli3, but instead renders it labile, leading to its proteasomal degradation via the SPOP/Cul3
complex. In fact, full-length Gli3 disappears with faster kinetics than the Gli3 repressor, the latter not
requiring SPOP/Cul3 or TrCP/Cul1. This may contribute to the increased Gli3 activator/repressor ratios
found in IFT mutants.
The Hedgehog (Hh) signaling pathway is important for es-
tablishment of left-right asymmetry and formation of various
organs during vertebrate embryonic development (30, 44, 49,
86), but it is mainly quiescent in adults. Inappropriate reacti-
vation, however, contributes to various cancers, thus providing
an impetus for further research (for recent reviews, see refer-
ences 33 and 73).
In vertebrates, the Hh signal transduction cascade is initi-
ated by the Hh ligand binding to its receptor Patched 1 (Ptch),
which abolishes Ptch’s repression of Smoothened (Smo), en-
abling this seven-transmembrane G-protein-coupled receptor-
like protein to transduce the Hh signal via a complex of cyto-
plasmic proteins (53, 62). This culminates in activation of a set
of transcription factors termed Gli1, Gli2, and Gli3 (69) which
modulate Hh pathway target gene transcription in the nucleus
(34, 68). Unlike in Drosophila melanogaster, where the single
Gli homolog Cubitus interruptus (Ci) functions as a transcrip-
tional activator when intact (CiFL) and as a repressor (CiR)
when cleaved (2, 4), Gli1 is thought not to be processed and to
function solely as a transcriptional activator to enhance signal-
ing (3, 15), being upregulated by pathway activity (45). By
contrast, Gli2 and Gli3 can be processed, acting as activators
when intact and as N-terminal repressors when cleaved (15, 41,
72, 76, 87).
Gli2 and Gli3 processing is phosphorylation and proteasome
dependent: in the absence of Hh, they are phosphorylated at
four to six sites by protein kinase A (PKA), which primes them
for further phosphorylation by glycogen synthase kinase 3
(GSK3) and casein kinase 1 (CK1) (56, 81, 87, 88). The
phosphorylated residues provide a high-affinity binding site for
TrCP, which in turn recruits the SCF (Skp1/Cullin1/F-box)
ubiquitin ligase complex to target full-length, 190-kDa Gli3
(Gli3FL) and 185-kDa Gli2 (Gli2FL) for cleavage via the
ubiquitin-proteasome pathway (81, 88) to generate the 83-
kDa Gli3 (Gli3R) and 78-kDa Gli2 (Gli2R) N-terminal re-
pressors, respectively, while the C termini are assumed to be
completely degraded (57). Hh stimulation represses this pro-
cessing and is thought to result in a predominance of full-
length (presumably activator) forms of Gli2A and Gli3A. Reg-
ulation of Gli3 processing is especially important in limb
development, with the appropriate ratio of Gli3FL and Gli3R
being essential for proper digit number and identity (42, 82)
and a diminishing gradient of Gli3R resulting in derepression
of Hh target genes from the anterior to the posterior of the
limb bud (26).
The paradigm of vertebrate Hh signaling has shifted consid-
erably with the seminal discovery that components of primary
cilia exert crucial roles during mouse tissue patterning and
development (29), which has been expertly reviewed in refer-
ences 16, 66, and 94. The eukaryotic primary cilium is a mi-
crotubule-based membrane protrusion that is assembled and
maintained by the bidirectional intraflagellar transport (IFT)
machinery (39). Mutations in IFT subunits Ift88, Ift172, and
Ift122 and motors Kif3a and Dync2h1 all result in polydactyly
due to impaired Gli3 processing (14, 25, 28, 29, 43, 47). More-
over, all three Glis and their binding partner Suppressor of
Fused (SuFu) have been found in primary cilia (25), while Ptch
is only there under unstimulated conditions, with Smo replac-
ing it upon Hh stimulation (13, 65).
Although Gli2 and Gli3 localize to the tips of primary cilia
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(25, 36) in an Hh-dependent manner in some cell lines (18), it
is not well understood how quickly this happens or what mod-
ifications occur in the cilia. By generating antibodies recogniz-
ing endogenous Gli2 and Gli3, we show here that full-length
Gli2 and Gli3 accumulate at cilium tips within 5 min of Hh
stimulation. This rapid Hh response is useful for investigation
of ciliary events in the Hh pathway, permitting us to discover,
for example, that PKA stimulation with forskolin (FSK) inhib-
its Gli3 accumulation. Furthermore, by Western blotting, we
unexpectedly found that while Hh signaling does inhibit en-
dogenous Gli3 processing, this does not result in accumulation
of the full-length Gli3 precursor, instead promoting its degra-
dation via SPOP, Cul3, and the proteasome, analogous to the
degradation of CiA by Hh-induced MATH and BTB domain-
containing protein (HIB) and Cullin3 (Cul3) in Drosophila (32,
35, 55, 97). Moreover, we confirmed that IFT is required for
efficient Gli3 processing and found it is also required for deg-
radation of Gli3FL.
MATERIALS AND METHODS
Cell culture. COS7, IMCD3 (murine intermedullary collecting duct), NIH 3T3
fibroblast, and S12 (Gli-luciferase stably transfected C3H10T1/2 osteoblast [21])
cells were maintained in high-glucose Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal bovine serum (FBS), 10 mM HEPES, and 2 mM
L-glutamine. S12 and 3T3 cells were never allowed to become 70% confluent,
to maintain proper ciliation and Hh signaling. Mouse embryonic fibroblasts
(MEFs) were isolated from embryonic day 10.5 (E10.5) embryos following stan-
dard procedures and maintained in the above medium plus 100 M -mercap-
toethanol (Calbiochem, La Jolla, CA), 100 M nonessential amino acids, 1 mM
sodium pyruvate, and 50 g/ml penicillin-streptomycin (all from Gibco, Grand
Island, NY). Hh stimulation was carried out by serum starving cells in appropri-
ate growth medium with only 0.5% FBS for 16 to 24 h and adding 200 ng/ml
octyl-Shh (80) (four times higher than that needed to saturate Gli-luciferase
activity in S12 cells) concurrently or after appropriate intervals for time course
analyses.
Antigen production. N- and C-terminal fragments of human Gli1 (amino acids
[aa] 2 to 151 and aa 958 to 1106 of NM_005269); Gli2 (aa 2 to 199 and aa 827
to 1126 of NM_030380, the nonsense-mediated mRNA decay sequence lacking
the 324-aa autoinhibitory N-terminal domain [72], which corresponds to aa 330
to 544 [Gli2N] and 1172 to 1471 [Gli2C] of the NM_005270 full-length Gli2
sequence); and Gli3 (conserved aa 2 to 184 and aa 1365 to 1547 of the 1,596-aa
M34366 Gli3 variant [70], selected as the most C-terminal region conserved in
both reported C-terminal frameshift variants [1,596 and 1,580 aa] of human and
mouse Gli3); and the mouse Smo C-terminal tail (aa 550 to 793 of P56726) were
subcloned into the in-house pSt239 expression vector with N-terminal unizyme
His (HQ) tags. Antigens were expressed in 58F3 Escherichia coli and purified
over a Ni-nitrilotriacetic acid (NTA) column (Qiagen, Valencia, CA) followed by
gel filtration on a Superdex 200 column in 20 mM 2-(morpholino)ethanesulfonic
acid (MES; pH 6.0), 6 M GdnHCl as previously described (37). Pooled purified
antigen fractions were reduced with 50 mM dithiothreitol (DTT), acidified with
2.5% (vol/vol) acetic acid, dialyzed against 1 mM HCl, and then flash-frozen in
the presence of 4% (wt/vol) mannitol. Gli C termini were purified over a Ni-NTA
column under native conditions in the presence of 5 mM -mercaptoethanol,
followed by anion exchange and size exclusion chromatography in phosphate-
buffered saline (PBS) containing 250 mM NaCl and 5 mM DTT. Antigens were
stored at 80°C until use.
Generation of anti-Gli rabbit pAbs. To maximize the chances of obtaining
functional antibodies for immunofluorescence (IF), half of each Gli antigen
preparation was fixed for 20 min at room temperature in 3% paraformaldehyde
(PFA; Electron Microscopy Sciences, Hatfield, PA), quenched with 50 mM
NH4Cl (Sigma, St. Louis, MO) for 10 min at room temperature, and then
dialyzed against PBS. The five fixed HQ-Gli N- and C-terminal antigens (Gli2C
did not yield sufficient material for immunization in rabbits) were mixed 1:1 with
their unfixed counterparts, and 500 g was used to immunize two New Zealand
White rabbits (labeled A and B), each using a 1:1 mixture of antigen and
complete Freund’s adjuvant, followed by 500-g boosts every other week with a
1:1 mixture of antigen and incomplete Freund’s adjuvant (Josman Labs, LLC,
Napa, CA). Immune sera from the 10th week were affinity purified on the
respective antigens bound to CNBr-activated Sepharose beads (GE HealthCare,
Uppsala, Sweden). HQ-Smo polyclonal antibody (pAb) 5928B antisera were
generated in the same way from aggregates of unfixed antigen (because it pre-
cipitated during PBS dialysis) but were purified on a low-pH antigen-coupling
resin (Actigel ALD; Sterogene, Carlsbad, CA) in PBS.
Development of anti-Gli MAbs. Ten BALB/c mice (Charles River Laborato-
ries, Hollister, CA) were hyperimmunized six times each with a mixture of 2 g
of a 1:1 mixture of fixed and unfixed HQ-Gli antigens in Ribi adjuvant (Ribi
Immunochem Research, Inc., Hamilton, MO), a mixture of the three N-terminal
antigens being injected into five mice and a mixture of the three C-terminal
antigens into another five mice, since the N termini were more immunogenic in
rabbits. The best two mice from each group were chosen based on high anti-Gli
antibody titers determined using an enzyme-linked immunosorbent assay
(ELISA; plates coated with a mixture of unfixed and 1% formalin-fixed Gli
antigens), as well as specific staining of transiently individually expressed myc-
tagged Glis in PFA-fixed COS7 cells by IF (see below for details). B cells from
the two selected mice in each group were pooled and fused with mouse myeloma
cells (X63.Ag8.653; American Type Culture Collection, Rockville, MD), in a
manner similar to that described previously (27, 38). After 10 to 12 days, the
supernatants were harvested and screened for antibody binding by ELISA (dis-
carding any that reacted with an irrelevant HQ-tagged protein) and IF. The
positive hybridomas were subcloned twice by limiting dilution and the superna-
tants purified by affinity chromatography (fast protein liquid chromatography;
Pharmacia, Uppsala, Sweden) as described before (27). The entire screen from
mouse inoculation to selection of the final clones (of 232 initial positive parental
hybridomas) took less than 11 weeks to yield 15 monoclonal antibodies (MAbs)
to six different Gli antigens; thus, our cofusion and coscreening strategy was
rapid as well as successful. Antibodies were sterile filtered and stored at 4°C in
PBS. While all 15 MAbs and all 5 pAbs recognized their respective transfected
Gli by IF and Western blotting, only the 4 MAbs and 2 pAbs that additionally
recognized endogenous Gli by at least one method are characterized herein.
IF. For antibody screening, COS7 cells were transiently transfected for 48 h
with full-length human myc-Gli1 (aa 2 to 1106 [78]), myc-Gli3 (aa 2 to 1596 [78]),
or human myc-Gli2C (aa 827 to 1126 subcloned into pRK5 via AscI and XbaI)
by using Fugene6 reagent (Roche Diagnostics, Indianapolis, IN) according to the
manufacturer’s protocol in 96-well black-walled microscopy plates (Whatman,
Clifton, NJ). Cells were fixed with 3% PFA for 20 min at room temperature,
quenched for 10 min in 50 mM NH4Cl, and permeabilized with 0.4% saponin
(Sigma) in PBS containing 1% bovine serum albumin (BSA) and 2% FBS.
Mouse sera were diluted 1:200 and 1:50 in saponin buffer; hybridoma superna-
tants were diluted 1:2. Final purified MAbs were used at 5 g/ml, pAbs at 2
g/ml, and 1 g/ml anti-myc tag 9E10 (19) was a positive control. Plates were
imaged with a 20 objective, using a Discovery-1 high-content screening micro-
scope (Molecular Devices, Downingtown, PA).
For detecting cilia and endogenous Gli3 with rabbit pAbs, cells were plated in
eight-well LabTekII microscope slides (Nalge Nunc, Naperville, IL), fixed and
permeabilized for 4.5 min at 20°C with 100% methanol to preserve centro-
somes, blocked in PBS–2% FBS–1% BSA, and stained for primary cilia with
anti-acetylated tubulin MAb 6-11B-1 (Sigma) at 1:3,000, centrosomes with 1
g/ml mouse anti--tubulin MAb GTU-88 (Sigma), and 3 g/ml rabbit anti-Gli3.
Antibody staining was detected with fluorescein isothiocyanate (FITC)-labeled
donkey F(ab)2 anti-mouse heavy and light chains and the equivalent Cy3–anti-
rabbit antibody (Jackson Immunoresearch, West Grove, PA). A four-step label-
ing protocol was employed to costain cilia with anti-Gli MAbs: (i) 1:2,000 rabbit
anti--tubulin (AccuSpecs, Westburg, NY) and 3 g/ml anti-Gli MAb; (ii) FITC–
anti-rabbit and Cy3–anti-mouse antibody; (iii) 10 g/ml mouse IgG to block
Cy3–anti-mouse antibody; (iv) Alexa 488 Zenon Fab anti-mouse IgG2b-labeled
6-11B-1, prepared according to the manufacturer’s instructions (Molecular
Probes, Carlsbad, CA). Then samples were postfixed in 3% PFA. For conve-
nience the Gli3N polyclonal 2676 was used in all quantitative experiments after
demonstrating similar results to 6F5 (see Fig. S2E in the supplemental material).
Slides were coverslipped in 4,6-diamidino-2-phenylindole (DAPI) containing
Vectashield (Vector Labs, Burlingame, CA) or ProLong Gold (Invitrogen) and
visualized by epifluorescence microscopy using a DeltaVision microscope (Ap-
plied Precision LLC, Issaquah, WA) powered by SoftWoRx software (version
3.4.4) and with a 60 objective. Figures were compiled using Photoshop CS
software (Adobe Systems, Inc., San Jose, CA).
Measurement of ciliary Gli signals. Qualitative assessment of the strength of
Gli staining at cilium tips was performed by scoring a positive signal as one that
was clearly distinct from the surrounding cytoplasmic and nuclear staining in the
same cell (see Fig. S2 and S3 in the supplemental material for examples). Around
200 cilia were counted for each sample, and the results are expressed as a
percentage of the total cilia counted (average of three independent data sets 	
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standard deviations [SDs], unless otherwise specified). P values for n indepen-
dent replicate experiments were calculated online using the unpaired t test with
n  1 degrees of freedom (GraphPad).
Quantitative analysis of Gli signal per cilium was performed using ImageJ
software (version 1.41; W. Rasband, NIH) by drawing an eight-by-eight circle
around the cilium tips in the acetylated tubulin channel and measuring the
integrated density in the Gli channel within the same area. The mean fluores-
cence intensity of all the cilia in one image was averaged with that of all the other
images in the same experiment, and SDs across all images were calculated.
siRNA transfection. Pools of predesigned On-Target-Plus small interfering
RNAs (siRNAs) for murine Gli2, Gli3, Smo, SPOP, Cul1, Cul3, IFT88, and
Dynch21 or siGenome siRNAs for mouse TrCP and Kif3a were purchased from
Dharmacon Inc. (Lafayette, CO). S12 cells were seeded into eight-well LabTekII
microscope slides at 3  104 cells/well or into six-well plates at 3  105 cells/well
and reverse transfected with 100 nM final siRNA pools, following a 20-min
preincubation of 1 nmol siRNA and 30 l DharmaFECT-2 (Dharmacon) in
Optimem (Gibco) at room temperature. After 48 h, cells were shifted into 0.5%
FBS medium for an additional 16 h to promote ciliation (with or without Hh for
the indicated times).
Immunoprecipitation and Western blot assays. Cells were serum starved to
induce ciliation for 16 to 24 h with or without 10 M MG132 (CalBiochem
474790), 100 nM HhAntag (21), 20 M cell permeant PKA inhibitor (myristoy-
lated 14-22 amide; CalBiochem 476485), 10 M H-89 (Calbiochem 371963), 10
M KT5720 (Calbiochem 420320), or 40 M forskolin (Calbiochem 344270), all
with or without Hh. Cell extracts were prepared by lysing EDTA-detached cells
with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris [pH 7.5], 150
mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate)
containing freshly added phosphatase inhibitor cocktails I and II (P-2850 and
P-5726; Sigma), Complete protease inhibitor cocktail (Roche), and 1 mM phe-
nylmethylsulfonyl fluoride (PMSF; Sigma) on ice for 30 min. Insoluble debris was
removed by centrifugation at 16,000  g for 20 min at 4°C.
Lysate concentrations were determined with the bicinchoninic acid (BCA) kit
(Pierce, Rockford, IL) and compared to BSA standards in RIPA buffer, and the
samples were equalized with RIPA buffer. Two-milligram aliquots of lysates were
precleared with 50 l of 50% (vol/vol) protein G-Sepharose beads, then incu-
bated with 2 g of pAb or 5 g of MAb for 1 h at 4°C, and then overnight with
50 l preequilibriated 50% protein G-Sepharose beads (GE HealthCare) on a
rotator. Immunoprecipitates (washed five times) and lysates were boiled in Lane
Maker sample reducing buffer (Thermo Scientific, Waltham, MA) for 5 min at
94°C, and half the immunoprecipitates or 30-g aliquots of the lysates were
separated on a 4 to 12% Tris-glycine SDS-PAGE (unless otherwise specified)
with Precision Plus protein standards (Bio-Rad, Hercules, CA) and transferred
to nitrocellulose membranes (all reagents from Invitrogen, Carlsbad, CA). Mem-
branes were incubated with 2 to 5 g/ml anti-Gli antibodies in 5% (wt/vol) milk
in Tris-buffered saline–0.05% Tween 20 followed by horseradish peroxidase
(HRP)-conjugated secondary antibodies. Endogenous Gli bands were visualized
with ChemiGlow substrate (Alpha Innotech, San Leandro, CA), while overex-
pressed myc-Gli and full-length human Gli2-myc-FLAG (Origene RC217291;
Fugene6-transfected into 293 cells as above) and tubulin loading controls (1:
10,000 dilution of 1A2 MAb; Sigma T9028) were visualized with ECL reagent
(GE HealthCare). Except where otherwise labeled (in Fig. 1 below and Fig. S1
in the supplemental material), MAb 6F5 was used for all Gli3 Western blot
assays.
Real-time qPCR. Total RNA was extracted from cells using the RNeasy
Protect minikit (Qiagen, Valencia, CA) according to the manufacturer’s proto-
col. On-column genomic DNA digestion was performed with an RNase-free
DNase set (Qiagen). cDNA synthesis from total RNA was conducted using the
High Capacity reverse transcription kit (Applied Biosystems, Foster City, CA)
with random hexamer primers. Quantitative PCRs (qPCRs) were performed in
triplicate on a Prism 7500 sequence detection system (Applied Biosystems) using
murine ribosomal protein L19 (mRPL19) as the endogenous control. Gene
expression was calculated using the relative quantification (2

Ct) method.
PCR primers and TaqMan probes are listed in Table S1 of the supplemental
material.
RESULTS
Generation of antibodies recognizing endogenous Gli2 and
Gli3. To detect endogenous Glis and to differentiate between
full-length protein and the N-terminal repressor, we raised
rabbit pAbs and mouse MAbs to the N and C termini of Gli1,
-2, and -3. We identified three antibodies that detected the N
terminus of Gli3 (Gli3N), pAb 2676 and MAbs 6F5 and 20B7,
two antibodies to the Gli3 C terminus (Gli3C), pAb 2438 and
MAb 18C3, and one antibody to the Gli2 C terminus (Gli2C),
MAb 1H6. All six Abs specifically detected their cognate trans-
fected antigens by IF and Western blotting (see Fig. S1 in the
supplemental material).
We found that Gli3 immunoprecipitated from ciliated S12
cell extracts with either Gli3N or Gli3C pAbs was readily
detected by MAb 6F5 as an 190-kDa full-length band (Fig.
1A), as seen in mouse embryos with other anti-Gli3 pAbs (41,
87). As expected, the Gli3N but not the Gli3C pAb pulled
down the processed N terminus of Gli3 (Gli3R) at 83 kDa
only in the absence of Hh. Immunoprecipitation using Gli3C
MAb or pAb pulled down Gli3FL but not a cleavage product
of the expected size for the Gli3 C terminus (107 kDa),
suggesting that the C terminus is rapidly degraded in the ab-
sence of Hh signaling, as is that of Ci in Drosophila (4), as
previously hypothesized (57, 83).
Furthermore, Gli3N MAbs 6F5 and 20B7 could detect en-
dogenous Gli3 in extracts of ciliated S12, 3T3, and MEF cells
without prior enrichment by immunoprecipitation (Fig. 1B and
FIG. 1. Detection of endogenous Gli3 in S12 cells. (A) Endoge-
nous Gli3 can be immunoprecipitated and detected by Western blot-
ting. Extracts of S12 cells treated for 16 h with () or without (-) Hh
were immunoprecipitated (IP) with anti-Gli3N pAb, anti-Gli3C pAb,
or MAb 18C3 and Western blotted (WB) with anti-Gli3N MAb 6F5 or
anti-Gli3C pAb as indicated (pAbs are shown in blue and MAb clones
are in red). Molecular mass markers in kDa are indicated on the left.
HC, antibody heavy chain. (B) 6F5 anti-Gli3N MAb is specific for Gli3.
Extracts of S12 cells transfected with nontargeting control (NTC) or
Gli3 siRNAs with or without Hh treatment for 16 h were Western
blotted with 6F5. Tub, antitubulin loading control. (C) Immunofluo-
rescence detection of endogenous Gli3. S12 cells transfected with
nontargeting control (siNTC) or Gli3 (siGli3) siRNAs with or without
30-min Hh stimulation were costained with 6F5 (red channel and
upper panels), cilia and centrosomes (anti-acetylated tubulin and anti-
-tubulin, respectively (Tub) (green channel), and DAPI (blue chan-
nel) for nuclei. Arrows indicate cilium tips. Bar, 20 m. Insets show 3
magnifications of the boxed regions.
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data not shown), with a stronger signal and fewer background
bands than all published antibodies (1, 11, 15, 28, 42, 51, 81,
87). As previously observed (42, 87), in the absence of Hh
Gli3R sometimes appears as a doublet (p83 and p75), possibly
a result of alternative cleavage or degradation stop sites during
proteasomal degradation of the C terminus (57, 83). All three
bands are specific, as they were abolished by siRNA knock-
down of Gli3 (Fig. 1B).
Full-length Gli3 and Gli2 accumulate at tips of cilia in
multiple cell types upon Hh stimulation. Gli3 and Gli2 are
found at the tips of cilia in cultured murine limb bud cells
(25), human embryonic stem cells (36), and MEF and 3T3
cells (12, 52), requiring Hh stimulation in the latter two cell
types (18). To determine if Gli3 ciliary localization is also
Hh dependent in S12 cells, we stained them with Gli3N
MAb 6F5, which detects both Gli3FL and Gli3R. Indeed,
Gli3 accumulated at distal tips of cilia in up to 80% of cells
following Hh stimulation (Fig. 1C; see also Fig. S2E in the
supplemental material). Additionally, we observed faint cy-
toplasmic puncta and a stronger nuclear signal, which, like
the cilium staining, were specific since they disappeared
following Gli3 siRNA treatment (Fig. 1C) or preincubation
of the antibody with Gli3N (see Fig. S2D). The nuclear
signal is likely predominantly Gli3R, since it mostly disap-
peared following overnight Hh stimulation (see Fig. S1F),
when Gli3R is virtually absent (Fig. 1B).
Similar Hh-dependent ciliary tip staining was found in
IMCD3, 3T3, and MEF cells (Fig. 2A to F) and with both of
the Gli3N Abs (Fig. 2B to F). Importantly, the Hh-stimulated
ciliary tip staining was also seen with anti-Gli3C (Fig. 2G and
H), indicating accumulated ciliary Gli3 is likely full-length, in
agreement with the inhibition of Gli3 processing by Hh and the
lack of Gli3R-green fluorescent protein in cilia (25, 51). Oc-
casionally Gli3 appeared as more than one spot, as if fixed in
transit to or from the cilium tip (Fig. 2I).
Anti-Gli2C MAb 1H6 recognizes transfected Gli2 (see Fig.
S1C in the supplemental material), but not endogenous Gli2
(data not shown), by Western blotting. However, it similarly
stained the tips of cilia upon Hh stimulation, and this signal
disappeared following siRNA knockdown of Gli2 (Fig. 2J to
L), suggesting Hh-accumulated ciliary Gli2 is similarly full-
length.
Hh-promoted ciliary localization of Gli3 and Gli2 is rapid
and requires active Smo. To further characterize Hh-regulated
Gli3 and Gli2 accumulation in cilia, we quantitated it (see Fig.
S3 in the supplemental material for details). We found only
10% of S12 cells had ciliary Gli3 or Gli2 in the absence of
Hh, while overnight Hh stimulation increased this to 50%
(Fig. 3A). Primary MEFs gave similar results, although the
basal ciliary levels of both Glis were higher, likely reflecting the
higher levels of endogenous Hh detected in these cells (see Fig.
S4A to C). Since Ptch exits and Smo enters cilia within 1 h of
Hh stimulation in MEFs (13, 65), we expected that Gli2 and
Gli3, as downstream effectors of Smo, would follow a similar
temporal trend of ciliary accumulation in S12 cells. Surpris-
ingly, however, Gli3 accumulated at the cilium tip as quickly as
5 to 10 min after Hh addition, peaking at 80% cilia in 30 to
60 min and declining somewhat thereafter, reaching a plateau
of 50 to 60% (Fig. 3B; see also Fig. S3A in the supplemental
material). We also measured the average fluorescence inten-
sity of Gli3 per cilium in the same set of images and found
good correlation at each time point, except at 0 to 5 min and
at 18 h, when the fluorescence intensity measurements were
slightly higher (Fig. 3C). This validates our less-time-consum-
ing qualitative scoring method, which was used in all further
experiments. Gli2 was similarly first enriched within 5 min,
peaked at 30 min in 50% of cilia, and then declined with
similar kinetics to Gli3, except it increased again after 2 h (Fig.
3B and D), probably due to Hh-dependent stabilization (56),
as Gli2 mRNA was not upregulated until 16 h (Fig. 3E). The
average fluorescence intensity of Gli2 per cilium also corre-
lated with the overall percentage of positive cilia, except for
being slightly lower at the 18-h time point (Fig. 3D).
To determine if Smo follows the same kinetics, we generated
a rabbit pAb that recognizes endogenous ciliary Smo (see Fig.
S5 in the supplemental material) and confirmed that, as in
MEFs, Smo is not significantly enriched in S12 cilia until 60
min after Hh addition, continuing to accumulate over 18 h to
70% of cilia (Fig. 3B). This is likely due to insufficient sen-
sitivity of the anti-Smo antibody, because knocking down or
inactivating Smo (with siRNAs [20] or the small-molecule in-
hibitors HhAntag [21, 67] and cyclopamine [9], respectively)
prevented Gli3 accumulation following 30 min of subsequent
Hh treatment, indicating active Smo as well as Hh is required
for Gli3 accumulation (Fig. 3F; see also Fig. S2F to K in the
supplemental material). Smo knockdown similarly inhibited
Gli2 accumulation in cilia (Fig. 3F). As Smo inactivation also
decreased the basal levels of ciliary Gli, endogenous Hh (Ihh
or Dhh) (see Fig. S4) is likely responsible for the low levels of
FIG. 2. Gli3 and Gli2 accumulate at cilium tips in response to Hh
in multiple cell lines. IMCD3 (A, B, and G to I), 3T3 (C and D),
primary E10.5 MEF (E and F), or S12 (J to L) cells were treated for
16 h in the absence or presence of Hh and costained with various
antibodies to Gli3 or Gli2 in the red channel (left), acetylated tubulin
(cilia) and -tubulin (centrosomes) together in the green channel
(middle), and merged with DAPI (blue) on the right. (A and B) Gli3N
MAb 6F5 (A) and 20B7 (B) staining of IMCD3 cells with Hh. (C to F)
Gli3N pAb 2676 staining of 3T3 (C and D) and MEF (E and F) cells
with or without Hh treatment; pAb 2676 also nonspecifically stains the
centrosome (see Fig. S2C and D in the supplemental material). (G and
H) Anti-Gli3C pAb 2438 staining of IMCD3 cells with or without Hh.
An additional Gli3 spot (arrowhead) along the cilium (I), here in
IMCD3 cells in the presence of Hh. (J to L) Anti-Gli2C MAb 1H6
staining of S12 cells without Hh (J), with Hh (K), and with Hh after
Gli2 siRNA transfection (L). pAbs are labeled alongside in blue, and
MAbs are in red, with  or - indicating the presence or absence of Hh,
respectively. White arrows indicate cilium tips.
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ciliary Gli2 and Gli3 under unstimulated conditions. Thus, it is
probable that Smo is translocated at the same time as or prior
to Gli2 and Gli3 but is simply more difficult to detect, being
spread all along the cilium, compared to the concentrated
single spot of Gli at the tip. While we cannot exclude that Smo
acts catalytically in cilia, similar to the inhibition of Smo itself
by Ptch (79), we think this unlikely, as the 10% Smo protein
remaining after knockdown (Fig. 3F, inset) was insufficient to
permit Gli accumulation. Interestingly, while cyclopamine en-
riched Smo in primary cilia in the absence of Hh, consistent
with recent findings (64, 91, 93), HhAntag did not (see Fig.
S5D in the supplemental material), suggesting that this inhib-
itor must stabilize a different, nonciliary conformation of Smo
than cyclopamine. Since both compounds inhibit signaling un-
FIG. 3. Gli3 and Gli2 accumulation at cilium tips is rapid and requires active Smo. (A) Quantitation of Gli3 and Gli2 accumulation at cilium
tips following Hh stimulation. S12 cells and E10.5 MEFs were treated for 24 h with or without Hh, then stained for cilia, centrosomes, and Gli3
(2676) or Gli2 (1H6). At least 150 cilia were scored (as in Fig. S3 of the supplemental material) in each of three (MEF) or five (S12) independent
experiments, and the mean 	 SD was plotted. Asterisks denote statistical significance between experiments with and without Hh according to the
t test. *, P  0.05; **, P  0.01; ***, P  0.001. (B) Time course of Hh-dependent Gli and Smo ciliary accumulation. S12 cells stimulated with
Hh for the indicated times were stained for Gli2 (1H6) or Gli3 (2676) and quantitated as for panel A. Smo (5928B) was stained and quantitated
as for Fig. S5C in the supplemental material. (C) Correlation between ciliary Gli3 qualitative scoring method used for panel B and quantitative
fluorescence intensities measured with ImageJ (arbitrary fluorescence units divided by 30 to fit on the same scale). (D) Same experiment as for
panel C, except this experiment compared ciliary Gli2 qualitative (F) and quantitative (E; 1.15) signals. (E) Gli3 mRNA levels are not altered
by Hh stimulation. S12 cells were treated with Hh for the indicated times, and then Gli1, Gli2, and Gli3 mRNA levels were assessed by qPCR,
normalized to RPL19, and expressed relative to unstimulated cells. Gli3 did not show any significant change, but Gli1 was upregulated by Hh as
expected. Data are the means and SD of two to four independent experiments for each time point. (F) Active Smo is required for Hh-dependent
Gli3 and Gli2 accumulation at cilium tips. NTC siRNA- or Smo siRNA-transfected S12 cells were treated with or without Hh for 30 min.
Alternatively, S12 cells were treated for 1 h with DMSO, 100 nM HhAntag (HhAn), or 5 M cyclopamine (CPM) with or without Hh for the final
30 min. Ciliary Gli3 or Gli2 was quantitated as for panel B in two independent experiments of 200 cilia. siNTC and DMSO gave similar results
for Gli3, and so the combined data are shown (Ctrl). **, P  0.01 versus Hh-treated control. The inset is a 14A5 MAb Western blot of Smo
knockdown versus siNTC with tubulin loading controls (Tub). (G) Smo knockdown or inactivation prevents Hh-mediated inhibition of Gli3
processing and degradation. S12 cells were treated as for panel F, except that Hh and drug treatments were for 16 h, and then blotting was
performed with 6F5 as for Fig. 1B. Lanes: 1, nontargeting control siRNA; 2, Smo siRNA; 3, DMSO control; 4, 100 nM HhAntag; 5,10 M MG132;
6, 5 M cyclopamine.
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der these conditions (96), accumulation of Smo in cilia per se
cannot be sufficient for subsequent Gli2 and Gli3 accumula-
tion; rather, Smo must accumulate in its active form, as occurs
during Hh stimulation. Alternatively, it is possible that a min-
imal level of active Smo protein is required, but its detectable
localization to cilia is not a prerequisite for Gli accumulation.
Smo knockdown or inactivation also prevented Hh from
inhibiting Gli3 processing (Fig. 3G), retaining both Gli3FL and
Gli3R at levels similar to those under nonstimulated condi-
tions. Surprisingly, while Hh stimulation in control cells inhib-
ited Gli3 processing as expected (15, 42, 87), this did not result
in increased levels of Gli3FL, instead consistently decreasing
them, an effect that also required active Smo (Fig. 3G). While
Hh inhibits Gli3 transcription in chick limb buds, as seen with
in situ hybridization (74) and in micromass cultures by North-
ern blotting (87), qPCR revealed no changes in S12 cell Gli3
mRNA over 72 h of Hh treatment that could account for the
loss of Gli3FL using any of three independent primer/probe
sets (Fig. 3E and data not shown). Rather, the Hh-mediated
decline in Gli3FL is due to posttranslational degradation, as it
was prevented by the proteasomal inhibitor MG132 (Fig. 3G),
which also inhibited processing, as expected.
Gli3FL and Gli3R are proteasomally degraded with distinct
kinetics. To further understand Gli3 processing and degrada-
tion, we compared Gli3 levels over a time course of Hh and/or
MG132 treatment, especially since IF revealed that ciliation
was disrupted after 16 h of MG132 treatment (data not
shown). We found that the levels of Gli3FL decreased as early
as 1 h post-Hh treatment (when cells and cilia appeared nor-
mal), with an apparent half-life of 2 h under our blotting
conditions (Fig. 4A and C). However, Gli3FL did not com-
pletely disappear, reaching a minimum plateau of 30% after
6 h. Proteasome inhibition with MG132 alone slightly in-
creased the basal levels of Gli3FL, consistent with inhibition of
Gli3 processing. Importantly, MG132 also inhibited the Hh-
dependent degradation of Gli3FL at all time points (Fig. 4A
and C), confirming that this is due to proteasomal degradation
and not loss of cilia.
By comparison, the Hh-dependent disappearance of Gli3R
was about twice as slow as that of Gli3FL (apparent t1/2, 4 h)
(Fig. 4A and D; see also Fig. S6A in the supplemental mate-
rial) but did continue to completion, with no detectable Gli3R
remaining after 16 h of Hh treatment at this exposure level
(Fig. 4A and D). This was likely a combination of proteasomal
degradation and inhibited formation via Gli3 processing, be-
cause adding MG132 together with Hh retarded the disappear-
ance of Gli3R at the same rate as MG132 alone. It is possible
that Hh and MG132 similarly inhibit the de novo formation of
Gli3R (by inhibiting Gli3FL processing). However, it is not
possible to distinguish whether Hh has no effect on the degra-
dation of preexisting Gli3R or if it accelerates it via a protea-
somal pathway.
To confirm that this was not an artifact of MG132 treatment,
we compared Gli3 levels over a time course of Hh treatment
with that of the protein synthesis inhibitor cycloheximide
(CHX). Gli3FL disappeared much faster upon treatment with
Hh than with CHX (Fig. 4B and E), confirming it is posttrans-
lationally degraded upon Hh stimulation. CHX did not in-
crease the rate of the Hh-mediated disappearance of Gli3FL.
Gli3R remained stable for 6 h under nonstimulated condi-
tions (CHX alone), and interestingly, adding CHX to the Hh
treatment actually inhibited the disappearance of Gli3R com-
pared to Hh alone (Fig. 4B and F; see also Fig. S6 in the
supplemental material), suggesting that the proteins that me-
diate Gli3R degradation may themselves be short-lived (turned
over within 3 h) and that their identities may be different from
those mediating Gli3FL degradation (see below).
Full-length Hh-activated Gli3 is degraded by the SPOP/
Cul3 complex. In the developing eye of Drosophila Hh-acti-
vated CiFL (CiA) is labile and proteasomally degraded in the
nucleus via binding to HIB (97), also known as Roadkill (35),
in a complex with the Cul3 ubiquitin ligase (55). Mammalian
SPOP (speckle type POZ protein) is 79% identical to HIB and
can functionally substitute for it in degrading Ci in vivo, as well
as degrading ectopically expressed Gli2 and Gli3 (97). We
therefore asked whether SPOP and Cul3 could be the E3 ligase
responsible for the lability of Gli3FL in Hh-stimulated S12
cells. Indeed, siRNA-mediated knockdown of either SPOP (by
80% at the mRNA level) or to a lesser extent Cul3 (by 70%)
stabilized Gli3FL 5- to 6-fold in the presence of Hh relative to
the nontargeting control (Fig. 4G; see also Fig. S8A and B in
the supplemental material). Importantly, Gli3FL was stabilized
relatively more in the presence than absence of Hh, leading us
to speculate that the nonphosphorylated form of Gli3FL may
be the preferred substrate of SPOP. (The 1.4-fold increase in
Gli3FL without Hh likely reflects the portion of Gli3FL acti-
vated by endogenous Hh.) This is consistent with the ability of
HIB to degrade a non-PKA-phosphorylatable mutant of Ci
and its preference for CiA over CiFL (97). Unlike HIB, how-
ever, SPOP itself was not significantly upregulated by Hh stim-
ulation at this time point (see Fig. S8A).
Gli3 processing in the absence of Hh was not inhibited by loss
of SPOP/Cul3 but was inhibited by loss of TrCP and the SCF
complex component Cul1, as expected from earlier results with
transfected Gli3 (81, 88). Both Gli3FL and Gli3FL:R ratios (Fig.
4H) increased more with knockdown of Cul1 (by 75% at the
mRNA level) than with TrCP, which we could not silence to
50% without inducing toxicity (see Fig. S8C and D in the sup-
plemental material). Note that unlike with MG132 (Fig. 4A and
D), Gli3R completely disappeared after 16-h Hh treatment in the
absence of either SPOP/Cul3 or TrCP/Cul1 complexes, suggest-
ing that yet another E3 ligase complex promotes its proteasomal
degradation. This would be consistent with our above hypothesis
that the mediators of Gli3R degradation are short-lived (3 h),
since the half-life of Cul3 is as long as 6 h in MEFs (48) and
similar to that of Cul1 in Drosophila larval cells (95). Taken
together, these results support the hypothesis (97) that the func-
tion of HIB/SPOP is conserved from flies to mammals, degrading
unphosphorylated Gli3FL in the presence of Hh, while the
TrCP/Cul1 complex processes phosphorylated Gli3FL into
Gli3R in the absence of Hh.
Inhibition of Gli3FL degradation increases the levels of
ciliary Gli3. The above results suggest that Hh-activated Gli3 is
labile because SPOP degrades presumably unphosphorylated
Gli3FL in an Hh-dependent manner. Since Hh also accumu-
lates Gli3FL at cilium tips (Fig. 2H), we speculated that in-
creasing the available pool of Gli3FL by SPOP knockdown
would result in accumulation of ciliary Gli3 in an Hh-depen-
dent manner. Indeed, siRNAs to SPOP (and to a lesser extent
Cul3) did cause a small but reproducible increase in the per-
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centage of Gli3-positive cilia after 16 h of Hh treatment, com-
pared to control Hh-stimulated cells (Fig. 4J) and, as expected,
this depended on the presence of Hh. More strikingly, an
2-fold increase in average Gli3 fluorescence intensity per
cilium was observed compared to control cells (see Fig. S7 in
the supplemental material), supporting our hypothesis that
unphosphorylated Gli3FL may be the accumulated species. As
expected from the 2-h half-life of Gli3FL in the presence of Hh
(Fig. 4C), 30 min of Hh stimulation was not sufficient to accu-
mulate this extra ciliary Gli3 in SPOP-deficient cells (Fig. 4K).
To confirm that Hh is required for ciliary Gli3 accumulation
and that mere accumulation of Gli3FL by inhibiting its pro-
FIG. 4. Gli3FL and Gli3R are processed and degraded by independent proteasomal pathways. (A) Gli3 Western blotting time course of MG132
with and without Hh treatment. S12 cells were serum starved for 16 h alone (0) or with Hh, 10 M MG132, or both for 1, 3, 6, or 16 h and then
blotted with 6F5 as described for Fig. 1B. The blot shown is representative of6 experiments, with white lines drawn between different treatments.
The empty blot between Gli3FL and Gli3R was excised to save space. (B) Gli3 Western blotting time course of cycloheximide with or without Hh
treatment. The experiment was similar to that in panel A, except 10 g/ml CHX replaced MG132. The single blot shown is representative of four
experiments, with white lines separating treatments. (C and D) Quantitation of Gli3 levels in panel A. Gli3FL (C) and Gli3R (D) bands were
normalized to the tubulin loading controls and plotted relative to untreated cells, assigned a value of 1 (means and SDs of 6 to 10 experiments,
one of which is shown in panel A). HM, Hh and MG132. For easier comparisons of Gli3FL and Gli3R, combined graphs are presented in Fig.
S6 of the supplemental material. (E and F) Quantitation of Gli3 levels in panel B. The same experiment was performed as in panels C and D, except
CHX (C) replaced MG132; data shown are from four experiments (10 for Hh), one being shown in panel B. C, CHX only; HC, Hh and CHX.
See also Fig. S6A, D, and E in the supplemental material. (G) SPOP or Cul3 knockdown inhibits the Hh-induced degradation of Gli3FL without
affecting processing. S12 cells transfected with siRNAs to SPOP or Cul3 were treated for 16 h in the presence or absence of Hh and then blotted
as described for panel A. The mean increase in Gli3FL relative to siNTC with or without Hh from three independent blots is shown underneath
this representative blot. (H) TrCP or Cul1 knockdown inhibits Gli3R formation while permitting Hh-dependent degradation of Gli3FL. The
experiment was similar to that shown in panel G, except siRNAs were to TrCP or Cul1. The mean Gli3FL:R ratio of two blots relative to siNTC
without Hh is shown underneath (the absence of Gli3R with Hh precluded ratio calculations). (I) Time course of Gli3 accumulation in cilia with
MG132 treatment. S12 cells treated with Hh or MG132 for different times were stained for ciliary Gli3 (2676 pAb) and quantitated as in Fig. S2
of the supplemental material. No cilia remained after 16 h of MG132 treatment, so that the curve ends at 6 h. (J and K) Knockdown of E3 ligases
increases Gli3-positive cilia. S12 cells transfected with siRNAs to TrCP, Cul1, SPOP, or Cul3 were treated with or without Hh for 16 h (J) or 30
min (K), stained, and quantitated as for panel I. The mean and SD of two to three independent experiments is shown. *, P  0.05.
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cessing or degradation with MG132 is not sufficient, we com-
pared ciliary Gli3 following Hh or MG132 treatment. At no
time point could MG132 substitute for Hh in accumulation of
ciliary Gli3 (Fig. 4I); thus, Hh activation is essential, and so we
speculate that it is Gli3A rather than Gli3FL that accumulates
in cilia.
Enhanced ciliary Gli3 was also observed following enrich-
ment of Gli3FL with siRNAs to Cul1 (and to a lesser extent
TrCP, again likely due to less efficient knockdown) (Fig. 4J
and K). However, unlike SPOP knockdown, a slight increase
also occurred in the absence of Hh, since Gli3FL already
accumulates in the absence of Hh via inhibited processing (Fig.
4H). A small but significant increase in Gli1 levels in the
absence of Hh resulted from knockdown of TrCP/Cul1 as
well as with SPOP (see Fig. S8A to D in the supplemental
material); thus, these results can likely be explained either by
accumulation of Gli3A (activated by endogenous Hh) or by
pathway derepression due to loss of Gli3R. However, the en-
hanced ciliary accumulation of Gli3FL under Hh-stimulated
conditions did not lead to significantly greater Gli1 transcrip-
tion compared to Hh-stimulated cells with intact E3 ligases.
This suggests either that Gli3A is not the major transcriptional
activator of Gli1 in S12 cells (perhaps because it is degraded
too quickly, as Gli1 is not elevated until 3 h of Hh stimulation
[Fig. 3E]) or that ciliary Gli3FL, while unphosphorylated, is
not the functional equivalent of Gli3A. Nonetheless, the levels
of ciliary Gli3 do mirror the subsequent levels of Gli1 tran-
script, but they are elevated more rapidly in response to Hh.
PKA-phosphorylated Gli3 does not accumulate in primary
cilia. The TrCP/SCF complex is specific for Gli3 phosphory-
lated by PKA/CK1/GSK3 in the absence of Hh (88), while
HIB (and presumably SPOP) can bind and mediate degrada-
tion of unphosphorylated CiA (32, 97). Since Hh stimulation is
required for both Gli3FL accumulation in cilia and SPOP-
mediated degradation, we hypothesized that ciliary Gli3 should
be non-PKA phosphorylated. To test this, we examined
whether accumulation or depletion of PKA-phosphorylated
Gli3 (using the PKA stimulator FSK or PKA inhibitors) pre-
vented or enhanced Gli3 accumulation in cilia, respectively.
The efficacies of FSK and three different PKA inhibitors,
H-89, KT5720, and myristoylated 14-22 amide, were first ver-
ified by testing their effects on Gli3 processing. As expected,
FSK stimulated Gli3 processing irrespective of Hh treatment,
as previously shown (81, 88). The possibility that FSK simply
stabilizes preexisting Gli3R rather than stimulating processing
per se was ruled out by its lack of effect in Cul1-depleted cells
(see Fig. S8G in the supplemental material). Conversely, all
three PKA inhibitors inhibited Gli3 processing and accumu-
lated Gli3FL (Fig. 5A; see also Fig. S8H in the supplemental
material). Further experiments utilized myristoylated 14-22
amide (henceforth abbreviated as PKAi) due to its higher
potency and greater PKA selectivity. Neither FSK nor PKAi
affected Gli3 mRNA levels, confirming that these changes are
posttranscriptional (see Fig. S8E). Furthermore, consistent
with PKA being a known negative regulator of the mammalian
Hh pathway (24, 75, 90), the 4-h FSK treatment inhibited
Hh-induced Gli1 transcription as well as decreasing basal lev-
els by 40% (see Fig. S8F). Conversely, PKAi caused a small
but significant upregulation of Gli1 mRNA (see Fig. S8F),
likely due to pathway derepression induced by loss of Gli3R.
As predicted, phosphorylation of Gli3 via FSK treatment
completely abolished its accumulation in cilia, both with and
without concomitant addition of Hh for 30 min (data not
shown) or for 4 h (Fig. 5B), even though Gli3FL is still
abundant at these time points (data not shown). Conversely,
4-h PKAi treatment led to accumulated Gli3 in cilia even
without Hh treatment and to a similar level as Hh treatment
alone (Fig. 5C). Hh stimulation was not additive with PKA
inhibition with respect to either the percentage of Gli3-
positive cilia or the stimulation of Gli1 transcription (Fig.
FIG. 5. Ciliary Gli3 is not PKA phosphorylated and is processed or
dynamically dephosphorylated. (A) FSK stimulates Gli3 processing
and the PKA inhibitor myristoylated 14-22 amide (PKAi) prevents it.
6F5 blots of S12 cells treated for 16 h with 40 M FSK or vehicle (Ctrl)
with or without Hh (left panel) or 20 M PKAi or vehicle (Ctrl) with
or without Hh (right panel). (B) FSK inhibits Hh-dependent accumu-
lation of Gli3 but not Smo in cilia. Cells were treated for 4 h with 40
M FSK or vehicle (Ctrl) in the absence of presence of Hh, then
stained and scored for ciliary Gli3 (2676, left) or Smo (right) as in Fig.
3B (mean and SD of two independent experiments). *, P  0.05; **,
P  0.01; ***, P  0.001 versus the corresponding control with or
without Hh. (C) PKA inhibition results in Hh-independent accumula-
tion of Gli3 and Smo in cilia. An experiment similar to that in panel B
was performed, except 20 M PKAi replaced FSK. (D) Endogenous
Gli3 is dynamically phosphorylated and dephosphorylated. Extracts of
S12 cells treated for 16 h () or not (-) with 10 M MG132 and 100
nM okadaic acid (O; lane 3), 40 M forskolin (F; lane 4), or both (lane
5) were run on a 4% SDS-PAGE gel and blotted with 6F5. Black
arrowhead, Gli3FL; gray arrow, presumptive phospho-Gli3FL; black
arrow, presumptive hyperphosphorylated Gli3FL. (E) At least 3 h is
required to accumulate hyperphosphorylated Gli3 in the absence of
proteasomal activity. Four to 12% 6F5 blots of S12 cells treated for the
indicated times with 10 M MG132, 100 nM OKA, or both. The
samples are all on the same blot, with vertical lines drawn for easier
viewing.
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5C; see also Fig. S8F in the supplemental material). This
confirms that non-PKA-phosphorylated Gli3 preferentially
accumulates in cilia and that one role of Hh is to antagonize
PKA activity toward Gli3 (87), as previously proposed for Ci
activation (90). This does not mean, however, that PKA
phosphorylation of Gli3 does not occur in cilia, just that
phospho-Gli3 does not accumulate at cilium tips.
Because FSK inhibits Gli3 accumulation as early as 30 min
(prior to any detectable changes in Gli1 transcription), we
wanted to determine whether this was due to inhibited trans-
location of Smo. Unlike Gli3, however, Smo did accumulate all
along cilia after a 4-h FSK treatment, to a comparable level as
with Hh treatment, and was further enhanced by Hh treatment
(Fig. 5B). This confirms previous observations that FSK inhi-
bition of pathway activity occurs downstream of Smo translo-
cation: Chuang et al. reported similar results in MEF cilia after
overnight FSK incubation (93), although by that time point
Smo accumulated only at the base of (not all along) the cilium,
which they hypothesized to be inactive Smo. The base of the
cilium cannot be the only location of inactive Smo, however,
since cyclopamine-inactivated Smo accumulates all along the
cilium (64, 91, 93) (see Fig. S5D in the supplemental material).
Furthermore, Smo also showed significant ciliary accumulation
in PKAi-treated cells, although to a lesser extent than with Hh
or FSK stimulation (Fig. 5C). Thus, while it is unclear whether
Smo all along cilia after FSK treatment is active or not, ciliary
Gli3 clearly only accumulates when not PKA phosphorylated.
Phospho-Gli3 is dephosphorylated or processed. To exam-
ine whether PKA-phosphorylated Gli3 is stable in the absence
of Hh, we attempted to enrich it with FSK or the protein
phosphatase inhibitor okadaic acid (OKA), both in the pres-
ence of MG132 to suppress any processing of phospho-Gli3.
Immunoblotting with 6F5 on a low-percentage gel permitted
resolution of a doublet of Gli3FL in the absence of MG132,
presumptively unphosphorylated and phosphorylated Gli3 (al-
though other posttranslational modifications are also possible),
both bands of which were stabilized by MG132 (Fig. 5D, lanes
1 and 2). Addition of OKA caused a marked decrease in
electrophoretic mobility (lane 3), while FSK did not unless
OKA was also present (lanes 4 and 5). Combined with the
knowledge that FSK must effectively stimulate the Gli3 phos-
phorylation cascade, because it efficiently stimulated Gli3 pro-
cessing (Fig. 5A), these data imply the existence of robust
phosphatase activity (in the absence of OKA). Although we
cannot exclude the presence of additional modifications, such
as ubiquitination during OKA treatment, these data are con-
sistent with the known accumulation of hyperphosphorylated
Ci by OKA (8) and imply that Gli3FL can be similarly hyper-
phosphorylated but subject to rapid processing or dephosphor-
ylation by an OKA-sensitive phosphatase, such as PP2A (31).
The OKA-induced retardation of migration in the presence of
MG132 was detectable as early as 3 h of treatment and was not
observed in the absence of MG132, due to enhanced process-
ing (Fig. 5E). Taken together, these results suggest that Gli3 is
dynamically phosphorylated and either processed or dephos-
phorylated and that non-PKA-phosphorylated Gli3FL prefer-
entially accumulates in cilia upon Hh stimulation.
IFT is required for efficient Gli3 degradation as well as
processing. Gli3 processing is thought to require cilia, or at
least intact IFT machinery, as Gli3R formation is impaired in
a variety of ift mutant mice, resulting in an increased Gli3FL:R
ratio and polydactyly in limb buds (16, 28, 29). However, our
discovery of the Hh-induced lability of Gli3FL makes it possi-
ble that this increased ratio could be at least partly due to
inefficient SPOP-mediated Gli3FL degradation. To determine
if this is the case, we knocked down the anterograde IFT
component IFT88 (25, 29, 43) and the anterograde and retro-
grade motors Kif3a and Dync2h1 (28, 47), respectively, with
siRNA and examined Gli3 levels with or without Hh treat-
ment. Kif3a knockdown was not very effective and so had less
of an effect on signaling, as assessed by Hh-stimulated Gli1
upregulation (Fig. 6E), than the 70% knockdown levels of
Dync2h1 and IFT88 (see Fig. S8I in the supplemental mate-
rial). As previously reported, in the absence of Hh disruption
of the latter two IFT components decreased production of
Gli3R by up to 60% (Fig. 6A and B) and increased Gli3FL
levels by 3-fold (Fig. 6C). As predicted, in the presence of
Hh, Gli3FL levels were indeed also elevated, by 10 times
compared to control siRNA-treated cells, consistent with im-
paired degradation in activated IFT-depleted cells. Thus, both
inhibition of Gli3R formation and inhibition of Gli3FL degra-
dation contribute to the increased Gli3FL:R ratios under these
conditions (Fig. 6D) and likely also in ift mutant mouse limb
buds, given the known expression of Hh there (7).
DISCUSSION
We have shown here using four new antibodies capable of
detecting endogenous Gli3 that this transcription factor local-
FIG. 6. IFT and microtubules are required for both processing and
degradation of Gli3FL. (A) Knockdown of IFT components inhibits
both Gli3FL processing and degradation. Shown is a 6F5 blot of S12
cells transfected with siRNAs to the NTC, IFT88, Dync2h1 (Dyn), or
Kif3a and treated for 16 h in the presence of absence of Hh. (B) Quan-
titation of Gli3R relative to siNTC from three blots, with a represen-
tative one shown in panel A. Note that the log scale better reveals the
decrease in Gli3R upon ift knockdown. (C) Quantitation of Gli3FL in
the same three blots as in panel B. (D) Gli3FL:R ratios from panels B
and C, normalized to 1 for siNTC. (E) Gli1 levels measured by qPCR
and normalized to siNTC plus Hh (16 h) as 100%.
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izes to the tips of primary cilia within 5 to 10 min of Hh
stimulation in four different cell lines. The ciliary Gli3 is full-
length, non-PKA phosphorylated, and depends on active Smo
as well as Hh. Full-length Gli2 also accumulates in cilia with
similar kinetics in a Smo- and Hh-dependent fashion. The
relative Gli2 and Gli3 accumulation levels upon Hh stimula-
tion are greater in cells expressing low levels of endogenous Hh
(like S12 cells) than in those with higher levels of Hh (like
MEFs), which might explain why ciliary Gli3 appeared to be
Hh independent in the Hh-expressing limb bud cultures, where
Gli3 was first seen in cilia (25). During review of this report,
Chuang and colleagues reported similar Hh-stimulated endog-
enous Gli3 and Gli2 accumulation in MEF cilia by using inde-
pendent antibodies (10), corroborating our results.
Our findings that ciliary Gli3 is full-length and requires both
Hh and lack of PKA phosphorylation are consistent with pre-
vious proposals that activation of Gli3FL into Gli3A occurs via
anterograde transport into cilia (28, 84). Full-length Gli2 also
accumulates in cilia in an Hh-dependent fashion with similar
kinetics and may similarly be activated into Gli2A at cilium tips
because in alien mutant mice (mutated in thm1/ift139) it accu-
mulates there due to impaired retrograde IFT, leading to ven-
tralized neural tubes characteristic of excessive Gli2A activity
(84). An activation step other than inhibition of PKA phos-
phorylation is also likely because although non-PKA-phos-
phorylatable mutants of Gli2 and Gli3 (P1 to P4) exhibit con-
stitutive activity, both require Hh for full activation in vivo
(58, 89).
In the absence of Hh, low basal levels of Gli2 and Gli3 are
seen at cilium tips, likely at least partly due to endogenous Hh
signaling, since their levels decrease upon Smo inhibition.
However, it is also possible that Gli2 and Gli3 constitutively
cycle through cilia at low levels, as has been proposed for Smo
itself (54), and that the rate of ciliary entry increases or ciliary
exit decreases upon Hh stimulation. Alternatively the rate-
limiting step in Gli2 and Gli3 translocation could be during the
switch from anterograde to retrograde IFT, resulting in tran-
sient accumulation that permits an Hh-dependent activating
modification. Or, something could specifically tether activated
Gli2 and Gli3 at cilium tips. Such a tether is unlikely to be Smo,
because it accumulates all along the cilia, not just at tips, in
response to Hh.
Since PKA has been localized to cilia (46, 60, 71), while the
downstream kinases CK1ε and GSK3 (23, 77) and ubiquitin
ligase components TrCP, Skp1, and Cul1 are all found at
centrosomes (22, 63), the simplest working model for Hh-
dependent Gli3 accumulation is as presented in Fig. 7. In the
absence of Hh, low levels of Gli3FL cycle in and out of cilia via
IFT, becoming phosphorylated by PKA but not accumulating
at cilium tips (Fig. 7A). Upon returning to the centrosome at
the base of the cilia, phospho-Gli3 is further phosphorylated by
GSK3 and CK1ε, becoming a substrate for TrCP/Cul1 ubiq-
uitination and processing into Gli3R by the proteasome, a
portion of which is also found at centrosomes (92). Gli3R then
translocates to the nucleus to inhibit Hh target gene expression
prior to being degraded by an unknown E3 ligase complex. We
suspect that the nuclear Gli3 signal detected with anti-Gli3N
MAb 6F5 is mainly Gli3R, because it mostly disappears fol-
lowing overnight Hh treatment, when little Gli3R remains (see
Fig. S1F in the supplemental material), although it is not yet
clear whether the rate of Gli3R degradation per se (as opposed
to inhibited formation) is affected by Hh.
In the presence of Hh (Fig. 7B), PKA is inhibited, prevent-
ing the Gli3 phosphorylation cascade and permitting unphos-
phorylated Gli3FL to accumulate at cilium tips, where we
propose yet-to-be determined modifications activate it into
Gli3A. While Gli3 accumulation can be detected faster than
the exchange of Ptch1 for Smo in cilia (65), it does depend on
active Smo. We speculate that Gli3A then translocates to the
nucleus, consistent with the notion that it can act as a tran-
scriptional activator (76) and is rapidly degraded (t1/2 of 2 h
in S12 cells) by the SPOP/Cul3 complex and nuclear protea-
somes (5), perhaps explaining its relatively minor contribution
to Gli1 transcription in these cells. Our proposed degradation
of Gli3A by SPOP/Cul3 is analogous to that of CiA by the
HIB/Cul3 complex in Drosophila. Like HIB, endogenous mam-
FIG. 7. Working model for Gli3 translocation, processing, and deg-
radation. (A) In the absence of Hh, Ptch, but not Smo, is present in
cilia, and Gli3 (and Gli2) may translocate at low levels into and out of
cilia (denoted by dashed arrows), where PKA could phosphorylate
them. However, cilia are not absolutely required for Gli3 processing,
so PKA phosphorylation could also occur in the cytoplasm, priming
Glis for further phosphorylation by centrosomal CK1ε and GSK3.
Phosphorylated Gli3 binds the centrosomal TrCP/Cul1 complex, be-
coming ubiquitinated and processed by the pericentrosomal protea-
some into Gli3R, which presumably translocates to the nucleus to
inhibit transcription by Gli2 and Gli1 prior to degradation by an un-
known E3 ligase complex. (B) In the presence of Hh, Smo replaces
Ptch in cilia and Gli3FL (and Gli2FL) accumulate at the distal tips via
IFT (denoted by solid arrows). PKA phosphorylation is inhibited,
preventing TrCP/Cul1 binding and processing. We propose an as-yet
unidentified modification (red circle) occurs at cilium tips to activate
the Gli3 (into Gli3A), which not only prevents it from being processed,
but also permits subsequent transport to the nucleus to allow activa-
tion of transcription of Hh target genes, including Gli1 and Ptch1.
Following this, Gli3A is ubiquitinated by the SPOP/Cul3 complex and
degraded by the proteasome.
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malian SPOP localizes to nuclear speckles (50) and can recruit
Cul3 from the cytoplasm along with degradation substrates
(40), likely including Gli3. Other scenarios for Gli3 phospho-
rylation and its inhibition by Hh are also possible, including
Hh-regulated relocalization to cilia of one or more of the
kinase or E3 ligase components themselves.
Our finding that endogenous Gli3FL (or Gli3A) is degraded
by endogenous SPOP in an Hh-dependent manner is in partial
agreement with recent findings by Chuang and colleagues, who
showed that overexpressed Gli3FL (and Gli2FL) could be de-
graded by overexpressed SPOP (10), albeit in large cytoplasmic
“blobs” reminiscent of inclusion bodies rather than in the nu-
cleus. However, they did not find degradation to be Hh depen-
dent, perhaps because overexpression disrupts Hh regulation;
indeed, transfected Gli accumulates in cilia without Hh (10,
25). Alternatively, the higher endogenous Hh levels in MEFs
may obscure the Hh dependence of SPOP degradation, al-
though exogenous Hh still promotes ciliary accumulation of
endogenous Gli in these cells.
Our results also have implications for understanding the role
of cilia in Gli3 function. While IFT renders Gli3 processing
more efficient, perhaps by concentrating Gli3 together with
PKA or other enzymes in cilia, accumulation of Gli3 in cilia per
se appears not to be absolutely required for processing. For
example, Gli3R formation occurred under conditions of Smo
inhibition or FSK treatment, when Gli3 does not accumulate in
cilia (although Gli3 could still transit through cilia undetected).
Since PKA is present in nonciliated organisms and is not re-
stricted to cilia, it is highly probable that some (maybe less
efficient) phosphorylation and processing of Gli3 can occur
without cilia. Indeed, every Gli3 Western blot assay of cilia-
deficient ift mutant mice has shown Gli3R is only diminished,
not absent (14, 25, 28, 29, 43, 47). Furthermore, our finding
that Gli3FL becomes more labile upon Hh stimulation (unless
IFT or SPOP is disrupted) suggests that at least some of the
increased Gli3FL:R ratio in ift mutants is due to impaired
activation and SPOP-mediated degradation rather than solely
due to impaired processing.
It should be noted that the Gli3 spot at the tip of cilia at any
one time is only a small fraction (likely less than 0.01%) of the
total Gli3 seen on a Western blot. The small fraction of Gli3 in
cilia makes it unlikely that Gli3 is simply protected from cen-
trosomal processing by sequestration at cilium tips in the pres-
ence of Hh. It may also explain the disconnect between the
rapid ciliary accumulation in minutes and prominent Gli3 band
intensity changes in hours. It has recently been proposed that
SuFu may regulate Gli2 and Gli3 stability by competing for
SPOP downstream of cilia altogether (10).
In summary, our novel antibodies recognizing endogenous
Gli2 and Gli3 are valuable tools for better understanding the
Hh pathway, and the Gli ciliary accumulation assay can be used
to decipher Hh signaling events upstream of Gli. We recently
found that Kif7, which itself concentrates at cilium tips upon
Hh stimulation, is required for maximal levels of Gli accumu-
lation per cilium (18), although it does not affect the overall
percentage of positive cilia. However, many questions remain
to be addressed, including how Gli2 and Gli3 accumulate at
cilium tips upon Hh stimulation, what happens to activate
them there, and how their transport to the nucleus from the
cilium and their subsequent degradation is regulated. Dyrk2
phosphorylates Gli2 and Gli3 and induces their degradation
(85), so it would be interesting to see if this kinase is ciliary or
affects Gli translocation. Alternatively, a phosphatase antago-
nizing PKA upon Hh stimulation could act in cilia to prevent
Gli3 processing, so investigation of PP2A, shown in Drosophila
to dephosphorylate Ci (31) and found in motile cilia (60), may
be warranted. Furthermore, the precise roles and Hh-depen-
dent localization of several other genes required for signaling
between Hh/Smo and Gli3 proteins, including Tulp3 (52, 59),
Rab23 (17), Tectonic (61), and Arl13b (6), remain to be de-
termined. Our Gli2 and Gli3 ciliary accumulation assay should
be a useful tool for probing such questions.
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